Michael Sidler

Co-Founder and General Partner

2006

Seed stage venture capital funds, investing in high tech companies in the field of ICT (internet/media/mobile) and Life Sciences (without drug development and invasive medtech). http://www.redalpine.com

Board of Directors

2024

Board Member

2024

Member Board of Directors

2022

Advisory Board Member

2021

Member of the Board

2018

Board Observer

2019

Board Observer

2015

Board Member

2020 - 2025

• Spearheaded the development of a groundbreaking linker technology for antibody-drug conjugates at Araris Biotech AG. • Collaborated with cross-functional teams to enable the attachment of payloads to 'off the shelf' antibodies, revolutionizing the ADC field. • Achieved significant advancements in ADC research, positioning Araris Biotech AG as a leader in the industry.

Member of the board

2015 - 2023